MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IAM
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Iambic Therapeutics (IAM) Ownership - Who owns Iambic Therapeutics?

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Financial Conglomerates
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
19.23M
P/E Ratio
N/A
Total Cash
1.54M
Projected Growth
N/A
Total Debt
1.19M
Revenue
23.93K
Risk (Beta)
0.01
Dividend Yield
N/A
Total Cash/Share
0.22
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI Trading Bots for IAM
Related Blogs
GENB

Generate Biomedicines GENB Stock: $27 Analyst Target Points to +107% Upside

NBTX

Why Is Nanobiotix (NBTX) Stock Down -0.3% Today?

CURX

Curanex Pharmaceuticals (CURX): Examining an Early-Stage Biotech's Botanical Pipeline

CDT

Why Is CDT Equity (CDT) Stock Down 26.72% Today?

HUMA

Humacyte (HUMA): Can It Climb Back to the $1.75 Analyst Target?

View all blogs related to
#Biotechnology
Interesting Articles

What does price to tangible book value (PTBV) mean?

What if I Need the Money in My IRA Before Retirement?

Is there any merit to the momentum theories?

What is an Asset-Backed Security?

What are the fundamental principles of Forex trading?

View all articles
A.I. Advisor
published General Information

General Information

a financial conglomerate

Industry Biotechnology

Industry
Financial Conglomerates
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Who owns Iambic Therapeutics? IAM symbol Ownership - Tickeron.com